Humanoid Robots
Humanoid robots are full-body autonomous machines built for human environments. The verified evidence on established participants is thin. Richtech Robotics has partnerships and pilot deployments but no major customers on record and no activity data in the last 90 days. Hyundai Motor's verified activity is limited to a leadership change at its Boston Dynamics unit. Competitive, supply-chain and export-control exposures are documented for Richtech.
Active institutional funds added a net $6.7 billion in Q2 2026, versus $459.8 million in Q1 2026. 50% of companies in this sub-theme saw increased active positions in Q2 2026.
Overview
Humanoid robots are general-purpose, full-body autonomous machines designed to work in spaces built for people, such as retail stores, restaurants, factories and commercial facilities. The sub-theme combines mechanical platforms, onboard perception and decision-making software, and AI computing hardware. Participants fall into two groups: robotics specialists such as Richtech Robotics, whose Dex platform sits alongside service robots like the DUST-E MX floor scrubber, and industrial groups that own robotics units, such as Hyundai Motor Group, which owns Boston Dynamics. Richtech uses NVIDIA computing platforms and robotics software frameworks for perception and on-device autonomy, and it works with Microsoft on AI workflows. Richtech's filings name Tesla's Optimus humanoid as a potential competitor to Dex, so the field includes automakers as well as dedicated robotics companies.
Investment Thesis
Investment thesis details are part of the Pro plan.
Bottleneck Tracker
Bottleneck details are part of the Pro plan.
Key Companies
Related Events
Agility Robotics is the first humanoid-focused company to list in the US, via a SPAC merger with Churchill Capital Corp XI. Its $2.5 billion valuation sits far below private rivals such as Figure AI at about $39 billion, while its financials show $1.8 million of revenue and a $138.1 million net loss. The listing gives public investors a reference point for pricing humanoid businesses with real deployments against those priced on future promise. About $465 million of gross proceeds funds the Digit 5 ramp, with deliveries targeted for the first half of 2027 against a $300 million-plus single-customer order. The FCC ban on new foreign-made advanced robotic devices and Unitree's roughly $40 billion Shanghai listing frame the competitive and policy backdrop.
The multi-robot, round-the-clock retail trial adds public proof that humanoids can work in real customer settings, supporting AGIBOT's IPO narrative and its roughly RMB 50 billion valuation. The lack of published intervention or failure data limits how far investors and buyers can draw conclusions about economics. It sits alongside the earlier 100-store X2 deployment and signals a push toward commercial retail and service use. Real-world edge cases generate training data for AGIBOT's GO-3 model, which could widen its lead over rivals shipping fewer units. Competitors such as Unitree, UBTech and Tesla Optimus face pressure to show comparable live deployments.
Tesla moving Optimus from prototype to a production line at Fremont is a milestone for the humanoid robot industry, though customer deliveries are not expected until the end of 2027. Musk's caution about a bumpy ramp and unresolved hand and durability issues tempers near-term volume expectations. Plans for a Fremont line targeting 1 million robots a year and an Austin line targeting 10 million raise demand expectations for actuators, sensors and AI compute. Competitors such as Agility Robotics, Figure AI, 1X and Sunday Robotics already have deployments or are preparing home shipments, so Tesla's entry intensifies competition. The planned AI5 chip install in April and the Optimus Academy data effort tie the robot's progress to Tesla's in-house AI silicon and training data.
The round underscores surging investor appetite for "physical AI" companies that aim to give robots general-purpose autonomy rather than single-task skills. FieldAI's valuation now rivals rivals Physical Intelligence (~$11B) and Skild AI (~$14B), signaling an intensifying capital race to build the dominant robot foundation model. Fresh capital should let FieldAI scale engineering and sales teams, deepen its roughly 30-customer base in construction, data centers and defense, and compete for scarce robotics talent from Google DeepMind, Tesla, Nvidia and Boston Dynamics. The financing also raises the bar for what counts as a credible valuation in robotics software, likely pressuring peers to raise larger rounds to keep pace. Longer term, success or failure of FieldAI's cross-platform approach will be a bellwether for whether a single software "brain" can generalize across humanoids, drones and industrial rovers, shaping how capital is allocated across the physical AI sector.
The new CSRC window guidance effectively freezes the Hong Kong and mainland IPO pipeline for most of China's 100-plus humanoid robot startups, cutting off a key capital-raising channel just as private funding rounds (47 billion yuan in Q2 alone) had surged. This forces unlisted startups to extend reliance on venture and government funding, likely accelerating consolidation among weaker players while advantaging commercially-further-along firms like Unitree, which already secured a fast-tracked Shanghai listing. The move also formalizes regulatory skepticism echoed by Unitree's own founder about near-term commercialization prospects, reinforcing a broader repricing of China AI/robotics valuations after Unitree's post-IPO share slide and UBTech's continued losses. Expect fewer, more selective Hong Kong tech listings in the near term, denting exchange listing volumes and investment banking fee pools tied to the sector. Longer term, the policy could improve the credibility of companies that do eventually list by filtering out speculative, revenue-light entrants, but in the interim it removes a major exit route for early-stage investors in China's embodied-AI boom.